Vimta Labs reported a steady 9.95% year-on-year growth in revenue for the September 2026 quarter, alongside a profit of Rs 20.61 crore. The company also confirmed the successful incorporation of its wholly-owned US subsidiary, Vimta Labs LLC, signaling a push for international expansion in its contract research and testing services.
Vimta Labs Q2 Net Profit Grows to Rs 20.6 Crore
Revenue from operations reached Rs 111.98 crore for the quarter, while profit for the period stood at Rs 20.61 crore.
Reader Takeaway: Steady top-line growth is supported by US market entry, though international scaling costs remain a key variable.
What just happened
Vimta Labs Limited has released its unaudited financial results for the quarter and half-year ended September 30, 2026. The company reported revenue from operations of Rs 111.98 crore, a 9.95% increase compared to Rs 101.85 crore in the same period last year. Profit for the period rose to Rs 20.61 crore from Rs 199.20 crore in Q2 of the previous fiscal year. Basic EPS stood at Rs 4.61 for the quarter.
Why this matters
The steady performance reinforces the stability of the company’s singular reporting segment: Contract Research and Testing Services. The official incorporation of its US subsidiary, Vimta Labs LLC, marks a strategic milestone that could open new revenue streams in the international market. Investors should look for management commentary on how the US entity will integrate with current operations.
Corporate Updates
Beyond the financials, the Nomination and Remuneration Committee granted 14,000 employee stock options (ESOPs) under the VLESOP-2021 plan on October 26, 2026. This move indicates a continued focus on employee retention and performance alignment as the company expands its footprint.
What to track next
Watch for future disclosures regarding the capital expenditure allocated to the new US subsidiary and any potential contracts or projects originating from the North American market.